AMP-activated protein kinase activity is required for vanadate-induced hypoxia-inducible factor 1α expression in DU145 cells

Carcinogenesis

Volumn 25, Issue 12, 2004, Pages 2497-2507

  Hwang, Jin Taek ^a   Lee, Minyoung ^a   Jung, Seung Nam ^a   Lee, Hye Jeong ^b   Kang, Insug ^a   Kim, Sung Soo ^a   Ha, Joohun ^a  

^a Kyung Hee University Hospital   (South Korea)

^b Dong A University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; VANADIC ACID;

ARTICLE; CANCER CELL; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOSINE TRIPHOSPHATE; CELL HYPOXIA; ENZYME ACTIVATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MULTIENZYME COMPLEXES; PROSTATIC NEOPLASMS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VANADATES;

EID: 10344221004     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh253     Document Type: Article

References (38)

1. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol., 15 551-578.
2. 2-regulated gene expression. FASEB J., 16, 1151-1162.
3. Hockel,M. and Vaupel,P. (2001) Tumor hypoxia: definitions and current clinical, biologic and molecular aspects. J. Natl Cancer Inst. 93, 266-276.
4. Semenza,G.L. (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med., 8, S62-S67.
5. Salnikow,K., Blagosklonny,M.V., Ryan,H., Johnson,R. and Costa,M. (2000) Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res., 60, 38-41.
6. Gao,N., Jiang,B.H., Leonard,S.S. et al. (2002) p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr (VI) in DU145 human prostate carcinoma cells. J. Biol. Chem., 277, 45041-45048.
7. Wang,G.L., Jiang,B.H. and Semenza,G.L. (1995) Effect of protein kinase and phosphatase inhibitors on expression of hypoxia inducible factor 1. Biochem. Biophys. Res. Commun., 216, 669-675.
8. Gao,N., Ding,M., Zheng,J.Z., Zhang,Z., Leonard,S.S., Liu,K.J., Shi,X. and Jiang,B.H. (2002) Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem., 277, 31963-31971.
9. Barceloux,D.G. (1999) Vanadium. J. Toxicol. Clin. Toxicol. 37, 265-278.
10. Cohen,M.D., K1ein,C.B. and Costa,M. (1992) Forward mutations and DNA-protein crosslinks induced by ammonium metavanadate in cultured mammalian cells. Mutat. Res., 269, 141-148.
11. Kerckaert,G.A., Leboeuf,R.A. and Isfort,R.J. (1996) Use of the Syrian hamster embryo cell transformation assay for determining the carcinogenic potential of heavy metal compounds. Fundam. Appl. Toxicol., 34, 67-72.
12. Sheu,C.W., Rodriguez,I. and Lee,J.K. (1992) Proliferation and morphological transformation of BALB/3T3 cells by a prolonged treatment with sodium orthovanadate. Food Chem. Toxicol., 30, 307-311.
13. Kraus,T., Raithel,H.J. and Schaller,K.H. (1989) [Quantitation of manganese and vanadium levels in the lung of 'normal' and occupationally exposed persons]. Zentralbl. Hyg. Umweltmed., 188 108-126.
14. Hardie,D.G., Carling,D. and Carlson,M. (1998) The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu. Rev. Biochem., 67, 821-855.
15. Kemp,B.E., Stapleton,D., Campbell,D.J. et al. (2003) AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans., 31, 162-168.
16. Lee,M., Hwang,J.-T., Lee,H.-J., Jung,S.-N., Kang,I., Chi,S.-G., Kim,S.-S. and Ha,J. (2003) AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells. J. Biol. Chem., 278, 39653-39661.
17. Laughner,E., Taghavi,P., Chiles,K., Mahon,P.C. and Semenza,G.L. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol., 21, 3995-4004.
18. Woods,A., Azzout-Marniche,D., Foretz,M., Stein,S.C., Lemarchand,P., Ferre,P., Foufelle,F. and Carling,D. (2000) Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol., 20, 6704-6711.
19. Hawley,S.A., Davison,M., Woods,A., Davies,S.P., Beri,R.K., Carling,D. and Hardie,D.G. (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem., 271, 27879-27887.
20. Zhou,G., Myers,R., Li,Y., Chen,Y. et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest., 108, 1167-1174.
21. Fantus,I.G. and Tsiani,E. (1998) Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects. Mol. Cell. Biochem., 182, 109-119.
22. Gingras,A.C., Raught,B. and Sonenberg,N. (2001) Regulation of translation initiation by FRAP/mTOR. Genes Dev., 15, 807-826.
23. Nave,B.T., Ouwens,M., Withers,D.J., Alessi,D.R. and Shepherd,P.R. (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J., 344 (Pt 2), 427-431.
24. Burnett,P.E., Barrow,R.K., Coben,N.A., Snyder,S.H. and Sabatini,D.M. (1998) RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc. Natl Acad. Sci., 95 1432-1437.
25. Ding,M., Li,J.-J., Leonard,S.S., YeJ.-P., Shi,X., Colburn,N.H., Castranova,V. and Vallyathan,V. (1999) Vanadate-induced activation of activator protein-1: role of reactive oxygen species. Carcinogenesis, 20, 663-668.
26. Qin,S. and Chock,P.B. (2003) Implication of phosphatidylinositol 3-kinase membrane recruitment in hydrogen peroxide-induced activation of PI3K and Akt. Biochemistry, 42 2995-3003.
27. 2O (2). Biochem. Biophys. Res. Commun., 287, 92-97.
28. Imoto,M., Kakeya,H., Sawa,T., Hayashi,C., Hamada,M., Takeuchi,T. and Umezawa,K. (1993) Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. I. Taxonomy, isolation and characterization. J. Antibiot., 46, 1342-1346.
29. Kakeya,H., Imoto,M., Takahashi,Y., Naganawa,H., Takeuchi,T. and Umezawa,K. (1993) Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. II. Structure determination. J. Antibiot., 46, 1716-1719.
30. Richard,D.E., Berra,E., Gothie,E., Roux,D. and Pouyssegur,J. (1999) p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J. Biol. Chem., 274, 32631-32637.
31. Fukuda,R., Kelly,B. and Semenza,G.L. (2003) Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res., 63, 2330-2334.
32. Hirota,K. and Semenza,G.L. (2001) Rac1 activity is required for the activation of hypoxia-inducible factor 1. J. Biol. Chem., 276, 21166-21172.
33. Russell,R.R., 3rd, Bergeron,R., Shulman,G.I. and Young,L.H. (1999) Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol., 277, H643-H649.
34. Ouchi,N., Kobayashi,H., Kihara,S., Kumada,M., Sato,K., Inoue,T., Funahashi,T. and Walsh,K. (2004) Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J. Biol. Chem., 279, 1304-1309.
35. Zou,M.-H., Hou,X.-Y., Shi,C.-M., Kirkpatick,S., Liu,F., Goldman,M.H. and Cohen,R.A. (2003) Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells: role of peroxynitrite. J. Biol. Chem., 278, 34003-34010.
36. Kovacic,S., Soltys,C.-L.M., Barr,A.J., Shiojima,I., Walsh,K. and Dyck,J.R.B. (2003) Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart. J. Biol. Chem., 278, 39422-39427.
37. Bolster,D.R., Crozier,S.J., Kimball,S.R. and Jefferson,L.S. (2002) AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J. Biol. Chem., 277, 23977-23980.
38. Richard,D.E., Berra,E. and Pouyssegur,J. (2000) Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem., 275, 26765-26771.